Our study demonstrates that elevated IGF-I:IGFBP-3 ratios among women with biopsy-proven benign breast disease were associated with higher TDLU counts, a measure of decreased TDLU involution, which has been linked to increased breast cancer risk. The gene discussed is IGF1; the disease is breast cancer.